Keros Therapeutics (KROS) Receivables - Net: 2021-2025
Historic Receivables - Net for Keros Therapeutics (KROS) over the last 2 years, with Sep 2025 value amounting to $3.5 million.
- Keros Therapeutics' Receivables - Net rose 800.00% to $3.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.5 million, marking a year-over-year increase of 800.00%. This contributed to the annual value of $2.7 million for FY2024, which is 1817.48% up from last year.
- Keros Therapeutics' Receivables - Net amounted to $3.5 million in Q3 2025, which was down 77.92% from $15.8 million recorded in Q2 2025.
- In the past 5 years, Keros Therapeutics' Receivables - Net registered a high of $18.0 million during Q4 2021, and its lowest value of $4,000 during Q2 2024.
- Over the past 3 years, Keros Therapeutics' median Receivables - Net value was $1.6 million (recorded in 2024), while the average stood at $5.0 million.
- Data for Keros Therapeutics' Receivables - Net shows a peak YoY soared of 395,300.00% (in 2025) over the last 5 years.
- Keros Therapeutics' Receivables - Net (Quarterly) stood at $18.0 million in 2021, then reached $143,000 in 2023, then skyrocketed by 1,817.48% to $2.7 million in 2024, then skyrocketed by 800.00% to $3.5 million in 2025.
- Its Receivables - Net was $3.5 million in Q3 2025, compared to $15.8 million in Q2 2025 and $17.3 million in Q1 2025.